SUVEN PHARMACEUTICALS
Back to Income Statement
|
SUVEN PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹1,340 Cr | ₹1,320 Cr | ₹1,010 Cr | ₹834 Cr | ₹378 Cr |
What is the latest Revenue of SUVEN PHARMACEUTICALS ?
Year | Revenue |
---|---|
Mar2024 | ₹1,340 Cr |
Mar2023 | ₹1,320 Cr |
Mar2022 | ₹1,010 Cr |
Mar2021 | ₹834 Cr |
Mar2020 | ₹378 Cr |
How is Revenue of SUVEN PHARMACEUTICALS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹1,340 Cr | 1.52 | |
Mar2023 | ₹1,320 Cr | 30.75 | |
Mar2022 | ₹1,010 Cr | 21.10 | |
Mar2021 | ₹834 Cr | 120.68 | |
Mar2020 | ₹378 Cr | - |
Compare Revenue of peers of SUVEN PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SUVEN PHARMACEUTICALS | ₹37,510.1 Cr | -1.6% | -2.6% | 0% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹390,864.0 Cr | -4.3% | -3% | -0.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹168,811.0 Cr | -3.3% | -7.4% | 34.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹124,352.0 Cr | 1.4% | 10.1% | 17.9% | Stock Analytics | |
CIPLA | ₹121,260.0 Cr | -4.4% | -0.5% | 0.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,786.0 Cr | -5.2% | -5.7% | -5.9% | Stock Analytics |
SUVEN PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SUVEN PHARMACEUTICALS | -1.6% |
-2.6% |
0% |
SENSEX | -1.1% |
-3.4% |
-1.1% |
You may also like the below Video Courses